El-Hoss, J <br/><br/>
A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.  [electronic resource] 

 -  The Journal of bone and joint surgery. American volume  Jul 2014 
 - e117 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1535-1386 
<br/><br/><label>Standard No.: </label>10.2106/JBJS.M.00862  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--administration & dosage<br/>Bone Morphogenetic Protein 2--administration & dosage<br/>Diphenylamine--administration & dosage<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Female<br/>Mice<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Neurofibromatosis 1--complications<br/>Osteogenesis--drug effects<br/>Pseudarthrosis--drug therapy<br/>Recombinant Proteins--administration & dosage<br/>Transforming Growth Factor beta--administration & dosage